Recognizing that not everyone might wish to know their genetic predisposition to Alzheimer's disease, direct-to-consumer genomics firm 23andMe last week gave customers the option to learn whether they have variants in the APOE gene linked to the disease.

Get the full story with GenomeWeb Premium

Only $95 for the first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.